BridgeMD
Does placement of a TAP block in patients undergoing laparoscopic inguinal hernia repair have a more efficacious analgesic effect than local infiltration at the surgical site: a randomized controlled trial.
EU CTIS ID: 2024-515759-39-00
What this study is testing
The primary objective of this study is to evaluate whether the use of a locoregional technique, ei-ther TAP block or port site wound infiltration, provides superior analgesic efficacy in postopera-tive pain management.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- ASA I to III patients
- Patients between 18 and 80 years old
- Patients undergoing a laparoscopic inguinal hernia repair operation.
You likely can't join if
- Patients with a BMI > 35 kg/m2
- Redo operations
- Patients with hemodynamic instability, such as “hypovolemia”
- Patients who are pregnant
- Patients labeled with ASA IV
- Patients who have demonstrated hypersensitivity/allergic reaction to “other local anesthetic of the amide type”
See the full eligibility criteria
- ASA I to III patients
- Patients between 18 and 80 years old
- Patients undergoing a laparoscopic inguinal hernia repair operation.
- Patients with a BMI > 35 kg/m2
- Redo operations
- Patients with hemodynamic instability, such as “hypovolemia”
- Patients who are pregnant
- Patients labeled with ASA IV
- Patients who have demonstrated hypersensitivity/allergic reaction to “other local anesthetic of the amide type”
- Patients known with a chronic pain syndrome
- Patients known with a polyneuropathy
- Patients taking daily opioids
- Patients younger than 18 years old and older than 80 years old
- Patients who did not give their consent for participation in the study
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.